| Product Code: ETC7652599 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Glucocorticoid Agonist Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Glucocorticoid Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Glucocorticoid Agonist Market - Industry Life Cycle |
3.4 Israel Glucocorticoid Agonist Market - Porter's Five Forces |
3.5 Israel Glucocorticoid Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Israel Glucocorticoid Agonist Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.7 Israel Glucocorticoid Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Glucocorticoid Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Glucocorticoid Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Glucocorticoid Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune and inflammatory diseases in Israel |
4.2.2 Rising awareness about the efficacy of glucocorticoid agonists for various medical conditions |
4.2.3 Technological advancements leading to the development of more effective glucocorticoid agonist products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of glucocorticoid agonist drugs in Israel |
4.3.2 Potential side effects associated with long-term use of glucocorticoid agonists |
5 Israel Glucocorticoid Agonist Market Trends |
6 Israel Glucocorticoid Agonist Market, By Types |
6.1 Israel Glucocorticoid Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Israel Glucocorticoid Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Israel Glucocorticoid Agonist Market Revenues & Volume, By Anti-inflammatory, 2021- 2031F |
6.1.4 Israel Glucocorticoid Agonist Market Revenues & Volume, By Eyes Disorders, 2021- 2031F |
6.1.5 Israel Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Glucocorticoid Agonist Market, By Products |
6.2.1 Overview and Analysis |
6.2.2 Israel Glucocorticoid Agonist Market Revenues & Volume, By Corticosterone, 2021- 2031F |
6.2.3 Israel Glucocorticoid Agonist Market Revenues & Volume, By Fluticasone Propionate, 2021- 2031F |
6.2.4 Israel Glucocorticoid Agonist Market Revenues & Volume, By Methylprednisolone, 2021- 2031F |
6.2.5 Israel Glucocorticoid Agonist Market Revenues & Volume, By Mometasone Furoate, 2021- 2031F |
6.2.6 Israel Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Glucocorticoid Agonist Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Glucocorticoid Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Glucocorticoid Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Glucocorticoid Agonist Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.5 Israel Glucocorticoid Agonist Market Revenues & Volume, By Ocular, 2021- 2031F |
6.3.6 Israel Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Glucocorticoid Agonist Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Glucocorticoid Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Glucocorticoid Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Glucocorticoid Agonist Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Glucocorticoid Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Glucocorticoid Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Israel Glucocorticoid Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Glucocorticoid Agonist Market Import-Export Trade Statistics |
7.1 Israel Glucocorticoid Agonist Market Export to Major Countries |
7.2 Israel Glucocorticoid Agonist Market Imports from Major Countries |
8 Israel Glucocorticoid Agonist Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed glucocorticoid agonist treatment |
8.2 Number of clinical trials conducted on new glucocorticoid agonist formulations |
8.3 Rate of adoption of glucocorticoid agonists by healthcare providers and patients |
9 Israel Glucocorticoid Agonist Market - Opportunity Assessment |
9.1 Israel Glucocorticoid Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Israel Glucocorticoid Agonist Market Opportunity Assessment, By Products, 2021 & 2031F |
9.3 Israel Glucocorticoid Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Glucocorticoid Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Glucocorticoid Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Glucocorticoid Agonist Market - Competitive Landscape |
10.1 Israel Glucocorticoid Agonist Market Revenue Share, By Companies, 2024 |
10.2 Israel Glucocorticoid Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here